Monograph #023

Chaste Tree

Vitex agnus-castus · Chasteberry · Vitex · Monk's Pepper
★★★★☆ Evidence Dopamine D2 / Prolactin Axis Progesterone / Luteal Phase Support Dried ripe fruit

Vitex has a well-characterized hormonal mechanism but a nuanced clinical evidence base. Effects are cycle-dependent and require multi-month observation. This section uses the hybrid Clinical Observations + Biomarker Targets format.

01 Identity 02 Compounds 03 Pathways 04 Biomarkers 05 Extraction 07 Dosing 08 Synergies 09 Safety 11 Evidence 12 Protocol

Botanical Profile

Vitex agnus-castus L. — Dried ripe fruit (berry). Native to the Mediterranean basin and Central Asia; naturalized in warm temperate regions worldwide; cultivated ornamental and medicinal shrub

Berries: aromatic, peppery, slightly bitter with warm spice notes reminiscent of black pepper and cardamom. Dried berries: grayish-brown, 3–5mm diameter. Powder: warm, pungent, slightly astringent. Tincture: aromatic and bitter with woody pepper character.

Species Integrity

Vitex adulteration is relatively uncommon but standardization inconsistency is the primary quality concern. Preparations vary widely from 0.5% casticin to unstandardized whole berry — potency differences are clinically significant.

Active Compound Profile

Iridoid glycosides (aucubin, agnuside)
0.3–2.0% in dried berry; agnuside is the primary marker compound
Dopaminergic D2 receptor agonism in the anterior pituitary; suppresses prolactin release; modulates LH pulsatility
Diterpenes (rotundifuran, vitexilactone, clerodadienols)
~0.1–0.5% dried fruit
Dopaminergic activity; mu-opioid receptor partial agonism; contribute to prolactin suppression
Flavonoids (casticin, vitexin, isovitexin, orientin)
0.1–0.5% dried berry; casticin is primary flavonoid marker
Antioxidant; mild estrogenic activity (ERβ selective); anti-inflammatory via NF-κB inhibition; casticin has antiproliferative activity in vitro
Essential oils (1,8-cineole, limonene, sabinene, linalool)
0.5–1.5% volatile oil content
Aromatic antimicrobial; mild sedative; contributes to GI motility modulation
Absorption

Consistent daily morning dosing: Vitex works through gradual normalization of the hypothalamic-pituitary axis; effects are not immediate. Daily consistent dosing maintains steady-state dopaminergic influence on prolactin and LH pulsatility.

Mechanism of Action

★★★☆☆ Dopamine D2 / Prolactin Axis Vitex iridoids and diterpenes bind pituitary dopamine D2 receptors, mimicking dopamine's inhibitory action on prolactin secretion. This lowers elevated prolactin, reducing its suppression of GnRH pulsatility and restoring LH/FSH balance.
★★★☆☆ Progesterone / Luteal Phase Support By normalizing LH pulsatility and reducing hyperprolactinemia, Vitex supports corpus luteum function and progesterone production in the luteal phase. Does not directly supply progesterone.
★★★☆☆ Mu-Opioid Receptor Partial Agonism Certain Vitex diterpenes act as partial mu-opioid agonists, contributing to its analgesic and mood-modulating effects relevant to PMS-D and dysmenorrhea
★★★☆☆ ERβ (Estrogen Receptor Beta) Modulation Flavonoids (particularly casticin and apigenin derivatives) bind ERβ with mild selectivity. ERβ activation in the brain may contribute to mood stabilization and reduced anxiety.
★★★☆☆ HPA Axis Stress Modulation Vitex appears to modulate the stress-induced prolactin surge and ACTH response, reducing the prolactin elevation caused by chronic stress

What It Moves in Your Labs

BiomarkerDirectionTargetMechanism
Serum Prolactin ↓ Decrease 5–20 ng/mL (normal female range) Dopamine D2 agonism in anterior pituitary suppresses prolactin secretion
Luteal Phase Progesterone ↑ Increase >10 ng/mL mid-luteal (Day 21) Normalized LH pulsatility supports corpus luteum function and progesterone output
LH/FSH Ratio Normalize LH:FSH ratio 1:1 to 2:1 Restoration of normal GnRH pulsatility and pituitary LH release pattern
Cycle Length Normalize 24–35 days (consistent) Downstream effect of prolactin normalization and LH/FSH rebalancing

Extraction & Preparation

Dried berry (whole or powdered): 100% iridoids + flavonoids; essential oils partially lost; diterpenes retained

Solubility · Water-soluble; extractable in ethanol-water mixtures; good aqueous solubilityMenstruum · 60–70% ethanolPlant material · Ripe dried berries, coarsely groundMaceration time · 4–6 weeks (agitate daily)Ratio · 1:5 (dried)

Dosing Framework

Morning dosing is essential: single morning dose aligns with the pituitary's prolactin secretion pattern and circadian dopamine receptor sensitivity. Divided doses are less effective.

Dose 1
Standard therapeutic: 20–40mg standardized extract (0.5% agnuside)
Once daily in the morning; the most studied dose range; equivalent to 500–1000mg dried berry
Dose 3
Whole berry: 500–1000mg dried powder daily
Less consistent potency; ensure product is ripe berry from confirmed V. agnus-castus

Synergy Partners

★★★☆☆ Ashwagandha (Withania somnifera) HPA axis adaptogen reduces stress-induced prolactin elevation; supports thyroid conversion (T4→T3); additive hormonal normalizing effect
★★★☆☆ Shatavari (Asparagus racemosus) Phytoestrogenic adaptogen supports female reproductive tissue; complements Vitex's prolactin-lowering with ovarian/uterine trophorestorative action
★★★☆☆ Maca (Lepidium meyenii) Hypothalamic glucosinolate metabolites support GnRH secretion; additive LH normalization; improves libido and energy
★★★☆☆ Lemon Balm (Melissa officinalis) Thyroid-modulating (mild anti-TSH antibody activity) + anxiolytic; addresses the nervous system component of PMS-D and hypothyroid anxiety
★★★☆☆ Progesterone (bioidentical, if prescribed) Vitex supports endogenous progesterone production; bioidentical supplementation fills the gap; not competing mechanisms
Signature Stack

THE HORMONAL HARMONY QUAD
Components: Vitex berry + Ashwagandha root + Shatavari root + Maca root · Multi-pathway convergence: Dopamine D2 prolactin suppression (Vitex) + HPA adaptogenesis and T4→T3 conversion (Ashwagandha) + ovarian trophorestorative phytoestrogenics (Shatavari) + hypothalamic GnRH support (Maca) · This stack directly addresses the HPG-HPA-thyroid axis disruption central to Hashimoto's-associated hormonal dysfunction: elevated prolactin, luteal phase deficiency, progesterone insufficiency, cycle irregularity, and stress-amplified autoimmune flares. · Practical integration: Vitex + Ashwagandha + Shatavari in morning tincture blend; Maca as 1–2 tsp daily in smoothie or oatmeal.

Contraindications & Interactions

Avoid Pregnancy Vitex is contraindicated during confirmed pregnancy. The dopaminergic and potential uterotonic activity presents theoretical risk. AHPA Class 2d.
Minor Hormone-sensitive conditions (ER+ breast cancer, endometriosis) Vitex flavonoids have mild ERβ activity. Theoretical concern in hormone-sensitive conditions, though evidence of harm is absent. ERβ selectivity may actually be protective, but data are insufficient.
Minor Dopamine agonist / antagonist medications Vitex has dopaminergic activity; theoretical interaction with antipsychotics (dopamine antagonists) and antiparkinsonian drugs (dopamine agonists). May reduce efficacy of dopamine antagonists.
Minor Pituitary adenoma (prolactinoma) Vitex is appropriate for functional hyperprolactinemia only. Pituitary adenoma requires pharmaceutical management (cabergoline). Do not substitute Vitex for medical treatment of confirmed prolactinoma.
Minor Oral contraceptives / HRT Theoretical pharmacodynamic interaction with exogenous hormones; clinical significance uncertain. May reduce efficacy of OCP by altering LH/FSH patterns.

Evidence Base

★★★★☆ PMS Symptom Relief Strong — Multiple RCTs with consistent benefit
★★★☆☆ Prolactin Normalization Moderate — Clinical evidence in functional hyperprolactinemia; mechanistic basis strong
★★★☆☆ Luteal Phase / Progesterone Support Moderate — Clinical evidence; mechanistic basis clear
★★★★☆ Cyclical Mastalgia Strong — RCT evidence; included in European clinical guidelines
★★★☆☆ Cycle Regularization in Amenorrhea Moderate — Case series and small RCTs; historically consistent

Evidence Gaps

The highest-value research gap for Meridian Medica: no published RCT has specifically evaluated Vitex in Hashimoto's-associated secondary hyperprolactinemia. Given that TRH elevation drives simultaneous TSH and prolactin elevation in hypothyroidism, Vitex's dopaminergic prolactin suppression could provide a targeted botanical intervention for this underrecognized driver of cycle irregularity in Hashimoto's women. A prospective study measuring prolactin, mid-luteal progesterone, and menstrual regularity in Hashimoto's women on stable levothyroxine would directly address this gap.

Quality Alert

Vitex adulteration is less common than price-point herbs but standardization fraud is the primary concern:

Protocol Integration

Layer 1: Hypothalamic / Autonomic — HPA axis, circadian rhythm, stress response

Layer 2: Systemic Nutritional Repletion — Micronutrient optimization, antioxidant defense

Layer 3: Gut Permeability / Microbiome — Tight junction repair, motility, SIBO management

Recipe Integration
Hormonal Harmony Morning Tincture Blend
40 mL Vitex in 100 mL blend; 3–4 mL dose daily
Feed the Markers

Vitex appears in the following Meridian Medica protocol contexts: